On Tuesday, Akoya Biosciences Inc (NASDAQ: AKYA) opened higher 18.75% from the last session, before settling in for the closing price of $1.12. Price fluctuations for AKYA have ranged from $0.93 to $3.42 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 14.10% annually for the last half of the decade. Company’s average yearly earnings per share was noted 28.14% at the time writing. With a float of $20.81 million, this company’s outstanding shares have now reached $49.84 million.
In an organization with 205 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 61.74%, operating margin of -48.22%, and the pretax margin is -59.28%.
Akoya Biosciences Inc (AKYA) Insider Updates
A key investor’s attitude towards the stock of the Medical Instruments & Supplies industry is another important factor to consider. The insider ownership of Akoya Biosciences Inc is 58.28%, while institutional ownership is 24.65%.
Akoya Biosciences Inc (AKYA) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 28.14% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.07% during the next five years compared to -23.03% drop over the previous five years of trading.
Akoya Biosciences Inc (NASDAQ: AKYA) Trading Performance Indicators
Check out the current performance indicators for Akoya Biosciences Inc (AKYA). In the past quarter, the stock posted a quick ratio of 0.40. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.96, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.63 in one year’s time.
Technical Analysis of Akoya Biosciences Inc (AKYA)
Let’s dig in a bit further. During the last 5-days, its volume was 0.25 million. That was inferior than the volume of 0.62 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 49.03%. Additionally, its Average True Range was 0.10.
During the past 100 days, Akoya Biosciences Inc’s (AKYA) raw stochastic average was set at 17.10%, which indicates a significant decrease from 68.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.40% in the past 14 days, which was higher than the 89.68% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.1876, while its 200-day Moving Average is $2.1522.
